Gene Expression Atlas home | about the project | faq | feedback | blog | das | api | help
C18orf8
REST API REST API
Homo sapiens
C18orf8 is differentially expressed in 196 experiments: 78 organism parts: lung, ovary, ... (76 more);, 137 disease states: normal, Huntington's disease, ... (135 more);, 68 cell types 324 cell lines 24 compound treatments and 62 other conditions.
Synonyms MIC1, HsT2591
Orthologs C18orf8 (Bos taurus)   ENSCING00000008161 (Ciona intestinalis)   C18orf8 (Gallus gallus)   RGD1311805 (Rattus norvegicus)   3110002H16Rik (Mus musculus)   C24H18orf8 (Danio rerio)   CG8270 (Drosophila melanogaster)   c18orf8 (Xenopus laevis)   C18orf8 (Canis familiaris)   (Compare orthologs)
InterPro Term Mic1
UniProt Accession Q96DM3, B7Z2Y1, F5H3Y7, F5H2W0
Search EB-eye ENSG00000141452
Show more properties
Experimental Factors
Organism part

studied in E-GEOD-15765, E-AFMX-5, E-GEOD-6573, E-MTAB-24, E-MTAB-25, ... (16 experiments)

3
1
Number of published studies where the gene is over/under expressed compared to the gene's overall mean expression level in the study.

anatomogram

Cell line

studied in E-GEOD-5258, E-GEOD-19639, E-GEOD-18005, E-GEOD-2450, E-GEOD-4717, ... (32 experiments)

Factor Value U/D Experiments
MCF-7
2
E-GEOD-3529, E-GEOD-20081
T84
2
E-GEOD-1474, E-MTAB-37
SW480
1
2
E-MEXP-1014, E-MTAB-37, E-GEOD-18005
MDA-MB-231
1
2
E-TABM-420, E-MTAB-62, E-GEOD-5823
SCaBER
1
E-MTAB-37
ssmcf7
1
E-MTAB-62
318 more value(s).


Cell type

studied in E-GEOD-21668, E-GEOD-19397, E-GEOD-3920, E-GEOD-20677, E-GEOD-13987, ... (29 experiments)

Factor Value U/D Experiments
testis - germ cell
2
E-AFMX-5, E-TABM-145
partially reprogrammed human induced pluripotent stem cell
2
E-GEOD-18265, E-GEOD-18147
CD56+ NK cells
2
E-TABM-145, E-AFMX-5
CD34+
2
E-AFMX-5, E-TABM-145
721 B lymphoblast
2
E-AFMX-5, E-TABM-145
CD19+ B cells (neg. sel.)
2
E-AFMX-5, E-TABM-145
62 more value(s).


Disease state

studied in E-GEOD-3307, E-GEOD-1577, E-GEOD-22148, E-GEOD-20602, E-MTAB-62, ... (28 experiments)

Factor Value U/D Experiments
normal
1
3
E-GEOD-3365, E-GEOD-23878, E-AFMX-6, E-GEOD-3790
Huntington's disease
2
E-AFMX-6, E-GEOD-3790
uterine fibroid
2
E-MTAB-62, E-GEOD-7307
juvenile dermatomyositis
2
E-GEOD-3307, E-MTAB-62
ovarian tumor, mucinosus
1
E-MTAB-62
chronic myelogenous leukemia, indolent
1
E-MTAB-62
131 more value(s).


Compound treatment

studied in E-GEOD-6907, E-GEOD-3720, E-GEOD-5099, E-MEXP-1958, E-MEXP-941, ... (17 experiments)

Factor Value U/D Experiments
bacterial endotoxin
1
E-GEOD-3284
M-CSF
1
E-GEOD-5099
Cxcl12
1
E-GEOD-7307
poly(I:C)
1
E-MEXP-1230
interferon-gamma + lipopolysaccharide
1
E-GEOD-5099
CNOT7+CNOT8
1
E-MEXP-2218
18 more value(s).


Agent

studied in E-GEOD-19519

Factor Value U/D Experiments
tunicamycin
1
E-GEOD-19519
DMSO
1
E-GEOD-19519
thapsigargin
1
E-GEOD-19519


BioSourceProvider
studied in E-GEOD-19519, E-GEOD-19480

Blood/non-blood meta-groups
studied in E-MTAB-62

Cancer site
studied in E-GEOD-4271

Cell treatment
studied in E-MEXP-1192

Cellular component
studied in E-GEOD-1400

Clinical history
studied in E-GEOD-22097, E-GEOD-19420, E-GEOD-19743, E-GEOD-7967, E-GEOD-21374, ... (7 experiments)

Clinical info
studied in E-GEOD-19743, E-MTAB-37, E-GEOD-19348, E-GEOD-21589, E-GEOD-16363 ... (5 experiments)

Clinical treatment
studied in E-GEOD-1743, E-GEOD-2171, E-GEOD-6532

coriell cell line repository identifier
studied in E-GEOD-19519

Developmental stage
studied in E-GEOD-20033, E-MEXP-2359, E-GEOD-6236, E-GEOD-2666, E-MTAB-62 ... (5 experiments)

Disease staging
studied in E-GEOD-19743, E-GEOD-3325, E-GEOD-21138

Environmental stress
studied in E-GEOD-1643, E-GEOD-1518, E-GEOD-3720, E-GEOD-4086

Estrogen receptor status
studied in E-GEOD-6532

Ethnic group
studied in E-GEOD-20194, E-GEOD-16716

family id
studied in E-GEOD-19519

Genetic modification
studied in E-GEOD-20847

Genotype
studied in E-TABM-1029, E-GEOD-3494, E-GEOD-21750, E-GEOD-22593, E-GEOD-2292, ... (8 experiments)

Gestation age
studied in E-GEOD-14334

369 groups
studied in E-MTAB-62

4 groups from blood to incompletely diff
studied in E-MTAB-62

96 groups
studied in E-MTAB-62

Growth condition
studied in E-MEXP-1220, E-MEXP-2657, E-TABM-127, E-GEOD-20504, E-GEOD-22278, ... (6 experiments)

Histology
studied in E-TABM-234, E-TABM-276

Individual
studied in E-TABM-325, E-MTAB-197, E-TABM-176, E-TABM-666, E-MEXP-1648, ... (23 experiments)

Infection
studied in E-MEXP-1274, E-GEOD-12254

Injury
studied in E-GEOD-19743

Karyotype
studied in E-GEOD-22056

Ki67 ihc
studied in E-GEOD-21653

Labeling
studied in E-LGCL-5

Material type
studied in E-MEXP-455

15 meta groups
studied in E-MTAB-62

4 meta groups
studied in E-MTAB-62

6 meta groups
studied in E-MTAB-62

Metastasis
studied in E-GEOD-18105

Molecular subtype
studied in E-GEOD-21653

Observation
studied in E-TABM-276

organ
studied in E-GEOD-24283

Organism
studied in E-TABM-84

Organism status
studied in E-GEOD-19188

Performer
studied in E-LGCL-5

Phase
studied in E-GEOD-4888

Phenotype
studied in E-GEOD-26495, E-GEOD-19703, E-GEOD-21750, E-GEOD-17636, E-GEOD-4600 ... (5 experiments)

Population
studied in E-MTAB-197, E-GEOD-4922

Progesterone receptor status
studied in E-GEOD-6532

Protocol type
studied in E-GEOD-22097, E-GEOD-21837, E-GEOD-19445, E-GEOD-19246, E-GEOD-1343 ... (5 experiments)

Replicate
studied in E-GEOD-18791

RNAi
studied in E-GEOD-12438, E-MEXP-1509, E-GEOD-1676, E-MEXP-101, E-GEOD-3697, ... (7 experiments)

Sample preparation
studied in E-GEOD-16728

sampleID
studied in E-GEOD-24283

Sampling time point
studied in E-GEOD-19743, E-GEOD-17400

sbr grade
studied in E-GEOD-21653

Sex
studied in E-GEOD-7307

Stimulation
studied in E-GEOD-11886, E-GEOD-11428

Subtype
studied in E-GEOD-24283

Survival time
studied in E-GEOD-3494, E-GEOD-4922, E-GEOD-19188

Tbefore
studied in E-GEOD-20194, E-GEOD-16716

Treatment
studied in E-GEOD-16837, E-GEOD-21909, E-GEOD-19246

Treatments comments
studied in E-GEOD-20194, E-GEOD-16716

Tumor grading
studied in E-GEOD-4290, E-GEOD-1561, E-GEOD-4922

Tumor size
studied in E-GEOD-6532

Vehicle
studied in E-GEOD-5258

Processing time: 0.373 secs.
 
Gene Expression Atlas 2.0.11.1- 12/23/11 3:09:34 PM